Biogen
Innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases.
Launch date
Employees
Market cap
€26.2b
Enterprise valuation
€30.5b (Public information from Sep 2024)
Share price
$197.59 BIIB
Cambridge Massachusetts (HQ)
Corporate Venture Fund: Biogen Idec New Ventures
No columns specified